Retention High With Biosimilar-to-Biosimilar Switch for Arthritis Retention High With Biosimilar-to-Biosimilar Switch for Arthritis

Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory arthritis.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news